This site is intended for health professionals only

Approval granted to sell DuoPlavin


Approval has been granted to sell combination blood thinner DuoPlavin/DuoCover, it has been confirmed.

The drug, which is manufactured by French drugmaker Sanofi-Aventis and New York-based company Bristol-Myers Squibb Co, will be used to treat blood clots in patients with heart conditions.

In a joint statement released by the two companies, they said the drug combines aspirin and the blood thinner Plavix, the world’s second best-selling drug.

They added the approval to sell the drug in Europe will ease the daily pill burden for patients.

But according to a spokeswoman for Bristol-Myers, there are currently no plans to introduce the drug to the US market.

Copyright Press Association 2010


Bristol Myers

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine